Thrivent Financial for Lutherans
RARE icon

Thrivent Financial for Lutherans’s Ultragenyx Pharmaceutical RARE Stock Holding History

Thrivent Financial for Lutherans’s Portfolio RARE Stock Details RARE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$550K Buy
2023
Q3 		– Sell
2023
Q2 		$1.75M Sell
2023
Q1 		$1.6M Buy
2022
Q4 		$1.71M Sell
2022
Q3 		$2.01M Buy
2022
Q2 		$2.21M Buy
2022
Q1 		– Sell
2021
Q4 		$1.75M Buy
2018
Q2 		– Sell
2018
Q1 		$449K Buy